← Every company
Merck & Co Inc Lobbying
What Merck & Co Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
MRK on carbonthat →Disclosed spend
$7.6M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Medicare/MedicaidTrade (domestic/foreign)Health IssuesPharmacyTaxation/Internal Revenue CodeAnimals
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | MERCK & CO, INC.Health IssuesMedicare/Medicaid | $4.2M |
| 20262nd Quarter (Apr 1 - June 30) | MERCK & CO, INC.Health IssuesMedicare/Medicaid | $2.3M |
| 20262nd Quarter (Apr 1 - June 30) | BALLARD PARTNERS | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | BALLARD PARTNERS | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | FORBES-TATEChemicals/Chemical IndustryTrade (domestic/foreign) | $80K |
| 20262nd Quarter (Apr 1 - June 30) | THE NICKLES GROUP, LLCHealth IssuesMedicare/Medicaid | $70K |
| 20261st Quarter (Jan 1 - Mar 31) | THE NICKLES GROUP, LLCHealth IssuesMedicare/Medicaid | $70K |
| 20261st Quarter (Jan 1 - Mar 31) | FORBES-TATEAnimalsAgriculture | $50K |
| 20262nd Quarter (Apr 1 - June 30) | W STRATEGIES, LLCMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPMedicare/MedicaidTrade (domestic/foreign) | $50K |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCPharmacyTrade (domestic/foreign) | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesTaxation/Internal Revenue Code | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK HEALTH STRATEGIES, INC. | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK HEALTH STRATEGIES, INC. | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPMedicare/MedicaidTrade (domestic/foreign) | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | FORBES-TATEMarine/Maritime/Boating/FisheriesNatural Resources | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | W STRATEGIES, LLCMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCTrade (domestic/foreign)Copyright/Patent/Trademark | $40K |
| 20262nd Quarter (Apr 1 - June 30) | CROSSROADS STRATEGIES, LLCTrade (domestic/foreign)Copyright/Patent/Trademark | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on MRK
Company overviewEverything on MRK in one place, with the price.SEC filingsWhat MRK's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat MRK's own officers and directors buy and sell.Who owns itEvery manager reporting a position in MRK.Funds holding itWhich funds and ETFs hold MRK, and how big a bet.Who lobbies for itThe lobbyists on MRK's account, and who they worked for.Federal contractsWhat federal agencies pay MRK.PatentsWhat MRK is filing at the patent office.